Page last updated: 2024-10-24

chlorpheniramine and Colorectal Cancer

chlorpheniramine has been researched along with Colorectal Cancer in 3 studies

Chlorpheniramine: A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.
chlorphenamine : A tertiary amino compound that is propylamine which is substituted at position 3 by a pyridin-2-yl group and a p-chlorophenyl group and in which the hydrogens attached to the nitrogen are replaced by methyl groups. A histamine H1 antagonist, it is used to relieve the symptoms of hay fever, rhinitis, urticaria, and asthma.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
de Lira-Quezada, CE1
Villarreal-Gonzalez, RV1
Gonzalez-Diaz, SN1
Carrasco-Diaz, LL1
Yanai, T1
Iwasa, S1
Hashimoto, H1
Kato, K1
Hamaguchi, T1
Yamada, Y1
Shimada, Y1
Yamamoto, H1
Ng, CV1

Other Studies

3 other studies available for chlorpheniramine and Colorectal Cancer

ArticleYear
Successful oxaliplatin desensitization protocol in a patient with colorectal metastatic cancer.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:2

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Chlorpheniramine; Colorectal Neoplasms; Desensitiza

2021
Successful rechallenge for oxaliplatin hypersensitivity reactions in patients with metastatic colorectal cancer.
    Anticancer research, 2012, Volume: 32, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Chlorpheniramine; Colorectal Neoplasms; Drug Hypersensitivity; Epine

2012
Hypersensitivity reactions to oxaliplatin in two asian patients.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:6

    Topics: Adult; Anti-Allergic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant;

2005